Dylan Morris
UnclaimedCurrent Firm
Insight Partners
Investments
7+ companies
Focus
AI, Cybersecurity
About Dylan Morris
Dylan Morris is a managing director at Insight Partners, which he joined in July 2021 to lead the firm's efforts in biology and biomedicine. His Insight partnerships include Profluent, ArrePath, Dem Bio, Unlearn.AI, Kyverna Therapeutics, Cirsium Biosciences and Capacity Bio, and his team focuses on technology-enabled approaches to drug discovery and development, new therapeutic modalities and curative therapies. He began his venture career at Innovation Endeavors, investing at the intersection of data science and life science, then worked at CRV, where he helped build the firm's bioengineering practice. Before investing he co-founded a biosensor company after leaving a biophysics PhD program at Caltech, where he worked in an early cryo-electron microscopy lab and built computational models of cells. In college he studied computational neuroscience, worked in a primate cognition lab and graduated with a degree in computer science.
Focus Areas
Investment Stage
Notable Investments
Previous Firms
Other Investors at Insight Partners
Investment Profile
Dylan Morris is a Managing Director, Insight Partners at Insight Partners, based in New York, NY.
Dylan's investment focus spans AI, Cybersecurity, Fintech, Digital Health, Other, primarily investing at the Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments include Profluent, ArrePath, Dem Bio, Unlearn.AI, Kyverna Therapeutics and 2 other companies. These investments span AI and Cybersecurity.
Before Insight Partners, Dylan worked at CRV, Innovation Endeavors. This breadth of experience across multiple firms provides a well-rounded perspective on the venture capital landscape.
Frequently Asked Questions
Who is Dylan Morris?
Dylan Morris is a Managing Director, Insight Partners at Insight Partners, based in New York, NY. Their investment focus includes AI, Cybersecurity, Fintech.
What does Dylan Morris invest in?
Dylan Morris focuses on investments in AI, Cybersecurity, Fintech, Digital Health, Other through Insight Partners. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
What are Dylan Morris's most notable investments?
Dylan Morris's notable portfolio investments include Profluent, ArrePath, Dem Bio, Unlearn.AI, Kyverna Therapeutics. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
What firm is Dylan Morris at?
Dylan Morris is currently at Insight Partners, headquartered in New York, NY, serving as Managing Director, Insight Partners. Previously, they worked at CRV, Innovation Endeavors.
Fund Operations Resources
Independent guides to the software and workflows venture investors and their firms use to run funds.
Best Fund Administration Software
Independent breakdown of fund administration platforms by fund size.
LP Reporting Software
Tools for capital account statements and investor updates.
Portfolio Monitoring Tools
How GPs track company performance across the portfolio.
VC CRM Software
Deal-flow and relationship management for investors.
Related tools and reading
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.